BioSpace News Archive

Deals

Azitra Relocates to Accommodate Sustained Growth

New space in Branford, CT enables the company to scale up clinical development of its pipeline portfolio, including lead candidate ATR-04 for cancer therapy-associated rash

June 9, 2020
·
3 min read
Drug Development

Sensorion Announces Positive Preliminary Preclinical Data From Its Otoferlin Gene Therapy Program

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces promising new preliminary data in non-human primates from its ongoing gene therapy program targeting the Otoferlin encoding gene.

June 9, 2020
·
5 min read
Policy

NanOlogy Announces Initiation of a Lung Cancer Clinical Trial Following FDA Allowances of Two IND Applications for NanoPac® in Lung Cancer

First-in-human clinical trial of intratumoral (IT) injections of NanoPac in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) is expected to begin enrollment in August

June 9, 2020
·
4 min read
Business

Quotient Limited Provides Update on COVID-19 Antibody Test Progress, Other Key Developments and Fourth Quarter and Full Year Fiscal 2020 Results

Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, summarized recent key achievements.

June 9, 2020
·
10 min read
Stilla Technologies Launches the World’s First Six-Color Digital PCR Instrument

Stilla Technologies, a leading provider of digital PCR solutions for high-precision genetic analysis, launched the world’s first six-color digital PCR instrument, the six-color Prism.

June 9, 2020
·
5 min read